Page 1 of Clinical Trials for "Peginterferon alfa-2b", 229 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Effect of Low-Dose PegIntron on ALT Normalization in Japanese Patients With Chronic Hepatitis C (Study P04508)(COMPLETED)
Last Updated: November 6, 2008
Condition(s): Hepatitis C, Chronic; Hepatitis C
2
Terminated
PEG-Interferon Alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer
Last Updated: May 16, 2011
Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
3
Not yet recruiting
Efficacy and Safety of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (P08034)
Last Updated: May 1, 2012
Condition(s): Chronic Hepatitis C
4
Completed
Three Regimens of PegIntron Plus Ribavirin in Previously Untreated Chronic Hepatitis C, Genotype 2 or 3 (Study P03548AM2)(COMPLETED)
Last Updated: April 8, 2010
Condition(s): Hepatitis C, Chronic
5
Completed
Peginterferon Dose Evaluations for Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03471AM1)(COMPLETED)
Last Updated: April 4, 2011
Condition(s): Hepatitis C, Chronic
6
Completed
Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603AM3)(COMPLETED)
Last Updated: March 24, 2011
Condition(s): Hepatitis D, Chronic; Hepatitis B, Chronic
7
Completed
Adherence in Patients Receiving PegIntron/Rebetol for Hepatitis C in Conjunction With a Psychotherapy Support Program (Study P04252)(COMPLETED)
Last Updated: February 25, 2011
Condition(s): Hepatitis C, Chronic; Hepacivirus
8
Terminated
Peg-Intron and Rebetol Therapy in Treatment of Naive Hepatitis C Patients: A Comparison of Race and Genotype on Treatment Outcome (Study P04212)(TERMINATED)
Last Updated: December 2, 2009
Condition(s): Hepatitis C, Chronic
9
Completed
Safety, Tolerability, PK and PD of SCH 900518 in Naive or Treatment-Experienced Subjects Infected With HCV Genotype 1 (Protocol No. P04695)(COMPLETED)
Last Updated: March 3, 2010
Condition(s): Hepatitis C, Chronic
10
Completed
Peg-Intron/Ribavirin in G 1 HCV for Non-Extended Versus 24 Week Extended Treatment After 24 Weeks (Study P04144)(COMPLETED)
Last Updated: February 25, 2011
Condition(s): Hepatitis C, Chronic
11
Terminated
Effects of 48 Weeks Versus 24 Weeks of Therapy With Peg-Intron/Ribavirin in Patients With Chronic Hepatitis C, Genotype 3 (Study P04143)(TERMINATED)
Last Updated: December 2, 2009
Condition(s): Hepatitis C, Chronic
12
Terminated
The Effects of PegIntron Plus Rebetol in Subjects With Chronic Hepatitis C Not Responding to Pegasys (Study P03833AM2)(TERMINATED)
Last Updated: October 1, 2009
Condition(s): Hepatitis C, Chronic
13
Completed
Efficacy of PegIntron (Peginterferon Alfa-2b) and Rebetol (Ribavirin) in Treatment-naïve Subjects With Chronic Hepatitis C in Clinical Practice in Greece (Study P05209)
Last Updated: October 4, 2011
Condition(s): Hepatitis C, Chronic; Hepatitis C
14
Completed
PegIntron Versus Adefovir in the Treatment of Chronic Hepatitis B (CHB) e Antigen Positive Patients in Taiwan (Study P04498)(COMPLETED)
Last Updated: November 18, 2010
Condition(s): Hepatitis B, Chronic (CHB)
15
Completed
Compliance of HCV Genotype 1 Infected Patients Receiving PegIntron/Rebetol and a Patient Assistance Program (Study P04671)(COMPLETED)
Last Updated: December 2, 2010
Condition(s): Hepatitis C, Chronic; Hepatitis C
16
Completed
Study of PEG-Intron Plus REBETOL in Pediatric Subjects With Chronic Hepatitis C (Study P02538AM1 Part 1)(COMPLETED)
Last Updated: October 13, 2009
Condition(s): Hepatitis C, Chronic
17
Completed
Study of HCV Genotype 1 Patients in the UK Treated With ViraferonPeg and Rebetol (Study P05269)(COMPLETED)
Last Updated: May 6, 2010
Condition(s): Hepatitis C, Chronic
18
Completed
Treatment of Patients With Chronic Hepatitis C With PegIntron as Monotherapy or in Combination With Ribavirin (Study P04437)(COMPLETED)
Last Updated: May 27, 2010
Condition(s): Hepatitis C, Chronic; Hepacivirus
19
Completed
Real-life Surveillance Study of Patients With Chronic Hepatitis C Treated With PegIntron Injector and Rebetol (Study P04538)(COMPLETED)
Last Updated: April 4, 2011
Condition(s): Hepatitis C, Chronic; Hepatitis C
20
Completed
Efficacy of PegIntron and Rebetol in Previously Untreated Patients With Chronic Hepatitis C Infected With HCV Genotype 1/4/5/6 (Study P04243)(COMPLETED)
Last Updated: March 24, 2011
Condition(s): Hepatitis C, Chronic

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?intr=%22Peginterferon+alfa-2b%22

Page 1 of Clinical Trials for "Peginterferon alfa-2b", 229 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About